The Clinical Diagnosis and Treatment for New Coronavirus Pneumonia Fanjun Cheng Yu Zhang Editors 123 The Clinical Diagnosis and Treatment for New Coronavirus Pneumonia Fanjun Cheng • Yu Zhang Editors The Clinical Diagnosis and Treatment for New Coronavirus Pneumonia Editors Fanjun Cheng Yu Zhang Department of Internal Medicine Department of Pharmacy Union Hospital, Tongji Medical College of Union Hospital, Tongji Medical College of Huazhong University of Science and Huazhong University of Science and Technology Technology Wuhan Wuhan China China ISBN 978-981-15-5974-7 ISBN 978-981-15-5975-4 (eBook) https://doi.org/10.1007/978-981-15-5975-4 © People's Medical Publishing House, PR of China 2020 Jointly published with People's Medical Publishing House, PR of China This work is subject to copyright. All rights are reserved by the Publishers, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publishers, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publishers nor the authors or the editors give a warranty, expressed or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publishers remain neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Springer imprint is published by the registered company Springer Nature Singapore Pte Ltd. The registered company address is: 152 Beach Road, #21-01/04 Gateway East, Singapore 189721, Singapore Preface Wuhan, China, as the initial place for the outbreak of COVID-19, not only had the cases from the earliest time, but also one of the largest infected populations until now. At the beginning of this outbreak, the Chinese government gathered profes- sional and experienced medical staff to support Wuhan nationally. Meanwhile, 46 hospitals were designated as specialized institutions for the COVID-19 patients. 16 mobile cabin hospitals were newly built to accept patients with mild or moderate symptoms, and 7 large general hospitals were designated for severe or critical cases. The West Campus of Wuhan Union Hospital, affiliated with the Tongji Medical College of HUST, is the one of the medical centers which accepted the largest num- ber of severe and critical patients during the epidemic. By 24:00 on March 20, 2020, a total of 1671 severe and critical COVID-19 patients were treated in the hospital. The number of patients who had been successfully cured and discharged from the hospital was 1069, and 147 patients died. At that time, there were still 401 severe and critical cases in-house. By making full use of its comprehensive medical power combined with special- ists’ skills of the 18 medical teams supporting Hubei, the West Campus of Wuhan Union Hospital has achieved better therapeutic accomplishments through compre- hensive and personalized treatment, combined with early rehabilitation and psycho- logical intervention. COVID-19 patients may also have medical conditions such as pregnancy, parturition, and urgent surgical conditions. It is still a great challenge to deal with these situations appropriately while ensuring the cure of COVID-19 and the protection of the medical staff. Based on the “Guidelines for the diagnosis and treatment of COVID-19” issued by the National Health Commission of PRC, this manual is prepared not only by referring to the research results of modern medicine and combining with the spe- cific circumstances of patients, but also by considering the allocation of medical resources. The content of this manual includes medical administration under emer- gent circumstances, prevention and control of nosocomial infection, clinical experi- ence on the diagnosis and therapy, radiographic inspection, laboratory diagnosis, inhibition of inflammatory cytokine storm, convalescent plasma therapy, TCM, etc. It is a collection of wisdom and practice of medical institutions at the highest level in China to cope with COVID-19. We believe the publication of this manual will benefit the countries which are currently dealing with COVID-19. v vi Preface One Earth, One Family. During the pandemic, nobody can step aside. China’s practice experience and outcome to combat COVID-19 will enable the rest of the world not to start from scratch but continue in China’s footsteps and fight the pan- demic more effectively. As the Chinese government is exporting anti-epidemic per- sonnel and materials to the world, we collected valuable information and experience from Wuhan Union Hospital by 18 medical troops from 12 provinces nationally during the past 2 months. We wish it is helpful for the prevention and control of COVID-19 in other countries. Wuhan, China Fanjun Cheng March 26, 2020 Yu Zhang Acknowledgments The book is written and finally published with the support of all parties, including the full cooperation of the medical management personnel from the West Campus of Wuhan Union Hospital, and the unremitting efforts of medical and nursing staff from 21 national medical teams mainly composed of those from Union Hospital. These medical professionals organized and wrote the contents of this book in their spare time after high-intensity work shifts treating COVID-19 patients. Our special thanks also go to Mr. Anbang Cheng, a volunteer who has just graduated from the Faculty of Agricultural, Life and Environmental Sciences in the University of Alberta, and temporarily suspends his study at the Faculty of Environmental Science in the University of Melbourne due to the epidemic. In addition to providing volun- teer service in the hospital logistics, he also made basic and great efforts for the English translation and organization of the book after the volunteer service. He is also the volunteer with the longest period of service in the West Campus of Wuhan Union Hospital for the COVID-19 prevention and control in Wuhan. We would like to thank Dr. Zhongbo Hu from Case Western Reserve University, USA, and Mu Hu, Solon High School Student, Solon, OH, USA, for their timely and free services in finalizing the English manuscript, and the People’s Medical Publishing House and Springer Publishing Company for their recognition of the book, which makes our experience and knowledge more accessible and helpful to other patients and people engaged in pursuit of preventing and treating COVID-19. Wuhan, China Fanjun Cheng April 19, 2020 Yu Zhang vii Contents 1 Emergency System of Designated Hospital for COVID-19 . . . . . . . . . . 1 Yong Gao, Yuncheng Li, Jian Luo, Hua Wang, Ying Su, Hui Chen, Xiaodan Han, and Hongbo Wang 1.1 Emergency Organizations and Their Responsibilities . . . . . . . . . . . . 2 1.1.1 Establishment of Emergency Medical Department . . . . . . . . 2 1.1.2 Innovation of Emergency Medical Administration . . . . . . . . 3 1.1.2.1 E stablishment of the Discussion System for Emergency Response to Difficult and Complicated cases, as well as Severe, Critical, and Death Cases . . . . . . . . . . . . . . . . . . . . . 3 1.1.2.2 C ontinuous Optimization of the Quality Control Mechanism of Emergency Medical Services . . . . . . 4 1.1.3 Emergency Nursing Management . . . . . . . . . . . . . . . . . . . . . 4 1.1.3.1 E stablishment of Emergency Nursing Management System . . . . . . . . . . . . . . . . . . . . . . . . . 4 1.1.3.2 Reasonable Allocation of Nursing Human Resources . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 1.1.3.3 F ormulate Relevant Systems, Processes, and Emergency Plans to Ensure the Safety and Efficiency of Nursing Work . . . . . . . . . . . . . . . . 5 1.1.3.4 P reparation of Ward Environment, Instruments, Equipment, and Materials . . . . . . . . . . . . . . . . . . . . . 6 1.1.3.5 T raining and Assessment for Strengthening Prejob Knowledge and Skills . . . . . . . . . . . . . . . . . . 7 1.1.3.6 I mplementation of Nursing Quality Management . . 7 1.1.3.7 S trengthening of Psychological Nursing and Humanistic Care for Patients . . . . . . . . . . . . . . . 8 1.1.3.8 P ay Attention to the Physical and Mental Health of Nursing Staff in the Isolation Ward Area . . . . . . . 9 1.1.4 Emergency Logistics Management in Designated Hospitals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 1.1.4.1 P romote the Leading Decision-making Position of Logistics Support Organizations. . . . . . . . . . . . . . 9 ix x Contents 1.2 Basic Medical Quality Management . . . . . . . . . . . . . . . . . . . . . . . . . 10 1.2.1 Ward Rounding System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 1.2.1.1 T hree-level Physician Ward Rounding System . . . . . 10 1.2.1.2 A ttending Physician Ward Rounding System . . . . . . 10 1.2.2 On Duty System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 1.2.2.1 F irst-line Doctor on Duty System . . . . . . . . . . . . . . . 11 1.2.2.2 S econd-line Doctor Duty System . . . . . . . . . . . . . . . 11 1.2.3 Consultation System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 1.2.3.1 General Consultation . . . . . . . . . . . . . . . . . . . . . . . . 11 1.2.3.2 Emergency Consultation . . . . . . . . . . . . . . . . . . . . . . 11 1.2.3.3 Surgical Consultation . . . . . . . . . . . . . . . . . . . . . . . . 12 1.2.3.4 Ordinary Consultation Mode . . . . . . . . . . . . . . . . . . 12 1.3 Admission and Treatment Process of COVID-19 . . . . . . . . . . . . . . . 12 1.3.1 Principles for Admission and Treatment of COVID-19 Patients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 1.3.2 Process for Admission and Treatment of COVID-19 Patients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 1.4 Medical Treatment Process for Pregnant Women . . . . . . . . . . . . . . . 13 1.5 Disposal Process of Remains of Patients with COVID-19 . . . . . . . . 14 References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 2 Hospital Infection Prevention and Control Against COVID-19 . . . . . . 17 Li Jiang, Qian Liu, Yunzhou Fan, Yan Jin, Fanjun Cheng, and Yong Gao 2.1 Regional Isolation and Management . . . . . . . . . . . . . . . . . . . . . . . . . 18 2.1.1 Daily Cleaning and Disinfection Process for Public Areas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18 2.1.2 Cleaning and Disinfection System for Fever Clinic . . . . . . . 19 2.1.3 Daily Cleaning and Disinfection System in Isolation Ward Area . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 2.1.4 Terminal Disinfection System in Isolation Ward Area . . . . . 22 2.2 Staff Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 2.2.1 Work Discipline of Medical Staff . . . . . . . . . . . . . . . . . . . . . 23 2.2.2 Precautions for Medical Staff to Take Public Transportation During COVID-19 . . . . . . . . . . . . . . . . . . . . . 24 2.3 Personal Protection in Different Scenes . . . . . . . . . . . . . . . . . . . . . . . 24 2.3.1 Personal Protection of Medical Staff . . . . . . . . . . . . . . . . . . . 25 2.3.1.1 P ersonal Protective Equipment and Application . . . . 25 2.3.1.2 Hand Hygiene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 2.3.1.3 P ersonal Protection for Specific Groups . . . . . . . . . . 26 2.3.1.4 P recautions for Removing Protective Equipment . . . 26 2.3.2 Prevention and Treatment Process for Accidental Entry of Patients or Medical Staff Wearing Contaminated Protective Articles in the Clean Area . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 2.3.3 Emergency Treatment Process for Occupational Exposure of Medical Staff . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 Contents xi 2.4 Biosafety Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 2.4.1 Infection Prevention and Control for Novel Coronavirus Specimen Collection and Transportation . . . . . . . . . . . . . . . . 28 2.4.1.1 P rotection of Sampling Personnel . . . . . . . . . . . . . . . 28 2.4.1.2 R equirements for Sampling Rooms in Fever Clinic . 28 2.4.1.3 Placement of Specimens . . . . . . . . . . . . . . . . . . . . . . 29 2.4.1.4 O ccupational Protection of Specimen Transporting Personnel . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 2.4.1.5 Specimen Transportation . . . . . . . . . . . . . . . . . . . . . 29 2.5 Patient Transfer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 2.5.1 Inter-hospital Transfer, i.e., Transfer Between Medical Institutions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 2.5.1.1 Transfer Workflow . . . . . . . . . . . . . . . . . . . . . . . . . . 30 2.5.2 In-hospital Transfer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 2.5.3 Patients Who Need to Be Transferred in Hospital Due to Special Examinations . . . . . . . . . . . . . . . . . . . . . . . . . 31 2.6 Digital Support for Epidemic Prevention and Control . . . . . . . . . . . . 32 2.6.1 Vigorously Carry out Internet Diagnosis and Treatment to Deal with the Epidemic . . . . . . . . . . . . . . . . . . . . . . . . . . . 32 2.6.2 Reduce Work Intensity and Infection Risk of Medical Staff . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 2.6.3 Teleconference, Consultation, and Training System . . . . . . . 33 References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34 3 COVID-19 Diagnosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 Hui Xing, Lian Yang, Mingxing Xie, Jing Wang, Yadan Wang, Fanjun Cheng, Yu Hu, and Weimin Xiao 3.1 Laboratory Testing for SARS-CoV-2 Infection . . . . . . . . . . . . . . . . . 36 3.1.1 Nucleic Acid Test . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 3.1.1.1 Sample Collection . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 3.1.1.2 Nuclei Acid Testing . . . . . . . . . . . . . . . . . . . . . . . . . . 37 3.1.2 Specific Neutralizing Antibody Test . . . . . . . . . . . . . . . . . . . 37 3.1.3 Pathogen Detection in Secondary Infection . . . . . . . . . . . . . . 37 3.2 Biochemical Examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38 3.3 Lung Imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 3.3.1 Imaging of Lungs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 3.3.1.1 CT Scan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 3.3.1.2 K eys for CT Diagnosis . . . . . . . . . . . . . . . . . . . . . . . 40 3.3.1.3 K ey for Examination and Imaging Diagnosis of Beside X-Ray . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41 3.3.1.4 K ey Points in Imaging Diagnosis of Severe Pneumonia on Bedside X-Ray Plain Film . . . . . . . . 43 3.3.1.5 COVID-19 Pneumonia Follow-Up . . . . . . . . . . . . . . 45 3.3.1.6 Discharge Criteria 45 3.3.2 Interventional Radiology Therapies . . . . . . . . . . . . . . . . . . . . 45